Oral propafenone therapy for children with arrhythmias: Efficacy and adverse effects in midterm follow-up

Gillette, 1985, Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy, JAMA, 253, 391, 10.1001/jama.1985.03350270089028 Garson, 1985, Atrial flutter in the young: a collaborative study of 380 cases, J Am Coll Cardiol, 6, 871, 10.1016/S0735-1097(85)80497-6 Garson, 1981, Ventricular dysrhythmias, 295 Garson, 1985, Prevention of sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias, J Am Coll Cardiol, 6, 221, 10.1016/S0735-1097(85)80279-5 Schwartz, 1975, The long QT syndrome, Am Heart J, 89, 378, 10.1016/0002-8703(75)90089-7 Thiene, 1988, Right ventricular cardiomyopathy and sudden death in young people, N Engl J Med, 318, 129, 10.1056/NEJM198801213180301 Griffin, 1988, Dilated cardiomyopathy in children, J Am Coll Cardiol, 11, 139, 10.1016/0735-1097(88)90179-9 Gillette, 1985, Supraventricular arrhythmias in children, J Am Coll Cardiol, 5, 122B, 10.1016/S0735-1097(85)80541-6 Coumel, 1979, Permanent form of junctional reciprocating tachycardia: mechanism, clinical and therapeutical implication, 347 Garson, 1983, The electrocardiogram in infants and children: a systematic approach, 241 Garson, 1983, The electrocardiogram in infants and children: a systematic approach, 251 Marcus, 1982, Right ventricular dysplasia: a report of 24 adult cases, Circulation, 65, 384, 10.1161/01.CIR.65.2.384 Nippoldt, 1982, Right ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients, 57, 404 Perry, 1990, Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence, J Am Coll Cardiol, 16, 1215, 10.1016/0735-1097(90)90555-4 Ravid, 1987, Safety of long-term propafenone therapy for cardiac arrhythmia, Experience with 174 patients. J Electrophysiol, 1, 580 Coumel, 1984, European experience with antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias, Am J Cardiol, 54, 60D, 10.1016/S0002-9149(84)80288-X Breithardt, 1984, Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up, Am J Cardiol, 54, 29D, 10.1016/S0002-9149(84)80283-0 Rinkeberg, 1988, Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia, Am J Cardiol, 62, 44D, 10.1016/0002-9149(88)90507-3 Guccione, 1989, Efficacy of propafenone in the young [Abstract], Circulation, 80, II-387 Weber, 1983, Experience with propafenone in the treatment of arrhythmias in pediatric patients, 185 Musto, 1988, Electrophysiologic effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular arrhythmias, Circulation, 78, 863, 10.1161/01.CIR.78.4.863 Cardiac Arrhythmia Suppression Trial (CAST) Investigation, 1989, Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, 321, 406, 10.1056/NEJM198908103210629 Nathan, 1984, Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent, Postgrad Med J, 60, 155, 10.1136/pgmj.60.700.155 Buss, 1985, Malignant ventricular tachyarrhythmias in association with propafenone treatment, Eur Heart J, 6, 424, 10.1093/oxfordjournals.eurheartj.a061881 Podrid, 1987, Aggravation of arrhythmia by antiarrhythmic drugs: incidence and predictors, Am J Cardiol, 59, 38E, 10.1016/0002-9149(87)90200-1 Fish, 1989, Incidence of death, cardiac arrest and proarrhythmia in young patients receiving flecainide and encainide, Circulation, 80, II-387 Zeigler, 1988, Flecainide for supraventricular tachycardia in children, Am J Cardiol, 62, 41D, 10.1016/0002-9149(88)90505-X Strasburger, 1988, Encainide for resistant supraventricular tachycardia in children: follow-up report, Am J Cardiol, 62, 502, 10.1016/0002-9149(88)90016-1 Olm, 1989, Severe reactive airway disease induced by propafenone, Chest, 95, 1366, 10.1378/chest.95.6.1366b Baker, 1987, Hemodynamic effect of propafenone and the experience in patients with congestive heart failure, J Electrophysiol, 1, 527, 10.1111/j.1540-8167.1987.tb01444.x Baker, 1984, Effect of propafenone on left ventricular ejection fraction, Am J Cardiol, 54, 20D, 10.1016/S0002-9149(84)80280-5